产品描述
It is estimated that 80 million adults in the US suffer from obesity.
mechanism of action
contains an active component called liraglutide, which is a glucagon-like peptide-1 (GLP-1) analogue. The drug, which can be administered intravenously, reaches activated neurons in brain regions and regulates the appetite and calorie intake.
contains an active component called liraglutide, which is a glucagon-like peptide-1 (GLP-1) analogue. The drug reaches activated neurons in brain regions, and regulates appetite and calorie intake."
Clinical trials on
The FDA's approval of was based on results from three Phase III clinical trials, known as SCALE (Satiety and Clinical Adiposity−Liraglutide Evidence in Nondiabetic and Diabetic people) studies, which were conducted for 56 weeks to evaluate the drug's safety and efficacy.
- Saxenda
- Ozempic
- Saxenda Pen
- Liraglutide injection
产能:
222222
运输时间表:
立即
Incoterms:
未通知包装明细:
未通知
更多关于
hebei Eminent technology co.,ltd
10-50
员工
500K - 1M
销售额(美元)
100%
% 出口销售额
Year
成立年份
业务类型
- Industry / Manufacturer
- Representative / Agent
- Distributor / Wholesaler
关键词
- 玻尿酸
- 蛋白线
- 美容产品
联系方式和位置
- youki liu
- +86 xxxxxxxx
- shijiazhuang / | 中国